Open AccessClinical overview of anti-CD19 BiTE® and ex vivo data from anti-CD33 BiTE® as examples for retargeting T cells in hematologic malignancies
Author(s) -
Gerhard Zugmaier,
Mark Klinger,
М В Шмидт,
М. Субклеве,
К. И. Киргизов,
Т. В. Шаманская
Publication year - 2016
Publication title -
rossijskij žurnal detskoj gematologii i onkologii
Language(s) - English
Resource type - Journals
eISSN - 2413-5496
pISSN - 2311-1267
DOI - 10.17650/2311-1267-2016-3-2-18-30
Subject(s) - blinatumomab , cd33 , medicine , ex vivo , leukemia , immunology , immunotherapy , cancer research , myeloid leukemia , cd19 , t cell , stem cell , antibody , in vivo , immune system , biology , cd34 , genetics , microbiology and biotechnology